NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Miaoshou Doctor

Miaoshou Doctor

Private
BeijingHealthcare & Life Scienceshttps://www.miaoshou.net/

Last Round

Series F

Aug 3, 2021

Est. Valuation

$4.25B

Total Funding Raised

$997.05M

Company Overview

Miaoshou Doctor is a healthcare technology company that operates an O2O platform integrating telemedicine, online pharmacy services, and health insurance solutions to connect patients, doctors, and hospitals.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, E-commerce, Pharma Supply Chain, Patient Engagement

Business Model

B2C

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

telemedicineinternet hospitalonline pharmacyO2O healthcareprescription managementchronic disease managementdigital healthe-healthpharmacy networkhealth insurancemedical consultationprescription fulfillmentAI healthcarepatient managementmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Miaoshou Doctor Comparables

Compare Miaoshou Doctor with similar companies based on industry and business-model similarity.

Miaoshou Doctor comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fangzhou Inc.
85%
Ping An Insurance (Group) Company of China, Ltd.
82%
Alibaba Group Holding Limited
81%

Miaoshou Doctor Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series FAug 3, 2021
Series EFeb 9, 2021
Series D ExtensionJun 14, 2020
Series C ExtensionJun 27, 2019
Series C ExtensionJan 7, 2019
Series B Extension
Sep 11, 2018

Miaoshou Doctor Investors

Notable investors and investment history

Miaoshou Doctor investors
InvestorRounds
Starworld CapitalSeries C Extension
CCIC CapitalSeries E
Gopher Asset ManagementSeries E
Hel Ved Capital ManagementSeries F
CITIC Securities Company LimitedSeries E, Series D Extension
CITIC SecuritiesSeries F, Series E, Series D Extension
B Capital GroupSeries F

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 3, 2021

    $232M round with participation from Archerman Capital and BOC International.

  • Feb 9, 2021

    $464M round led by Tencent and HongShan.

Miaoshou Doctor Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Miaoshou Doctor Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Miaoshou Doctor's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Year Founded2015
Last FundingAug 3, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.